Vikram Aroma
BSE: VIKRAMAR · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Vikram Aroma's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Vikram Thermo India Limited is a specialty chemical manufacturer based in Ahmedabad, focusing on the production of pharmaceutical excipients and cosmetic ingredients. Its core offerings include pH-sensitive polymers for enteric coating and sustained-release applications, alongside fragrance stabilizers.
Business Model
The company generates revenue through the research, development, and manufacturing of specialized chemical products sold to the pharmaceutical and personal care industries. It leverages its proprietary Drugcoat brand to provide functional coating solutions for oral solid dosage forms.
Growth Outlook
Growth is driven by the company's significant export presence and the increasing demand for advanced pharmaceutical excipients in global markets. Continued investment in its manufacturing facility in Indrad supports its capacity to serve international pharmaceutical and personal care clients.
Key Risks
- Regulatory Compliance. The company faces risks associated with stringent international pharmaceutical quality standards and regulatory approvals for its excipients.
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks and basic methacrylates can significantly impact profit margins.
- Foreign Exchange Risk. As a company with a significant export presence, earnings are susceptible to volatility in currency exchange rates.
- Competitive Pressure. The specialty chemicals sector is highly competitive, requiring continuous R&D investment to maintain market share against global players.
Start your research today
Unlock AI insights, financials, peers and live data on Vikram Aroma and 5,000+ companies — free.
Key Metrics
P/E
28.3x
Q4 FY26 · standalone
EV/EBITDA
9.1x
Q4 FY26 · standalone
NET PROFIT MARGIN
2.2%
Q4 FY26 · standalone
DEBT TO EQUITY
0.1x
Q4 FY26 · standalone
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Vikram AromaVIKRAMAR | ₹25 Cr | 30.17 | 11.08 | — | 10.8% | 3.9% | 6.1% | -20.2% |
Kronox Lab Sciences LimitedKRONOX | ₹666 Cr | 23.05 | 16.30 | 6.1% | 38.7% | 27.7% | 35.9% | +11.2% |
Black Rose IndusBLACKROSE | ₹584 Cr | 26.01 | 16.40 | — | 11.0% | 13.9% | 18.9% | +19.1% |
Vipul OrganicsVIPULORG | ₹506 Cr | 63.11 | 30.62 | 7.7% | 10.4% | 8.9% | 13.4% | +29.6% |
Plastiblends India LimitedPLASTIBLEN | ₹493 Cr | 11.54 | 6.83 | 5.5% | 9.2% | 9.7% | 12.8% | +0.5% |
Aarti SurfactantAARTISURF | ₹458 Cr | 24.91 | 9.80 | 25.2% | 6.1% | 7.7% | 12.4% | +19.0% |
As of Q4 FY26
Financials
Vikram Aroma
BSE: VIKRAMAR · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Vikram Aroma's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Vikram Thermo India Limited is a specialty chemical manufacturer based in Ahmedabad, focusing on the production of pharmaceutical excipients and cosmetic ingredients. Its core offerings include pH-sensitive polymers for enteric coating and sustained-release applications, alongside fragrance stabilizers.
Business Model
The company generates revenue through the research, development, and manufacturing of specialized chemical products sold to the pharmaceutical and personal care industries. It leverages its proprietary Drugcoat brand to provide functional coating solutions for oral solid dosage forms.
Growth Outlook
Growth is driven by the company's significant export presence and the increasing demand for advanced pharmaceutical excipients in global markets. Continued investment in its manufacturing facility in Indrad supports its capacity to serve international pharmaceutical and personal care clients.
Key Risks
- Regulatory Compliance. The company faces risks associated with stringent international pharmaceutical quality standards and regulatory approvals for its excipients.
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks and basic methacrylates can significantly impact profit margins.
- Foreign Exchange Risk. As a company with a significant export presence, earnings are susceptible to volatility in currency exchange rates.
- Competitive Pressure. The specialty chemicals sector is highly competitive, requiring continuous R&D investment to maintain market share against global players.
Start your research today
Unlock AI insights, financials, peers and live data on Vikram Aroma and 5,000+ companies — free.
Key Metrics
P/E
28.3x
Q4 FY26 · standalone
EV/EBITDA
9.1x
Q4 FY26 · standalone
NET PROFIT MARGIN
2.2%
Q4 FY26 · standalone
DEBT TO EQUITY
0.1x
Q4 FY26 · standalone
Peers · Specialty Chemicals
As of Q4 FY26